Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial

被引：0

作者：

N C Tebbutt

M M Cummins

T Sourjina

A Strickland

G Van Hazel

V Ganju

D Gibbs

M Stockler

V Gebski

J Zalcberg

机构：

[1] Austin Health,Department of Medical Oncology

[2] PO Box 5555,undefined

[3] Studley Road,undefined

[4] Heidelberg,undefined

[5] Melbourne,undefined

[6] Victoria 3084,undefined

[7] Australia,undefined

[8] National Health and Medical Research Council Clinical Trials Centre,undefined

[9] University of Sydney,undefined

[10] Locked Bag 77,undefined

[11] Camperdown,undefined

[12] Sydney,undefined

[13] New South Wales 1450,undefined

[14] Australia,undefined

[15] Monash Medical Centre,undefined

[16] 246 Clayton Road,undefined

[17] Clayton,undefined

[18] Melbourne,undefined

[19] Victoria 3168,undefined

[20] Australia,undefined

[21] Sir Charles Gairdner Hospital,undefined

[22] Hospital Avenue,undefined

[23] Nedlands,undefined

[24] Perth,undefined

[25] Western Australia 6009,undefined

[26] Australia,undefined

[27] Frankston Hospital,undefined

[28] PO Box 52,undefined

[29] Frankston,undefined

[30] Melbourne,undefined

[31] Victoria 3199,undefined

[32] Australia,undefined

[33] Christchurch Hospital,undefined

[34] 2 Riccarton Avenue,undefined

[35] Addington,undefined

[36] Christchurch,undefined

[37] Canterbury 8011,undefined

[38] New Zealand,undefined

[39] Peter MacCallum Cancer Centre,undefined

[40] St Andrews Place,undefined

[41] East Melbourne,undefined

[42] Melbourne,undefined

[43] Victoria 3002,undefined

[44] Australia,undefined

来源：

British Journal of Cancer | 2010年 / 102卷

关键词：

advanced gastric cancer; advanced oesophageal cancer; cisplatin; 5-fluorouracil; capecitabine; docetaxel;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：475 / 481

页数：6

共 50 条

[41] Phase II study of weekly docetaxel and capecitabine in patients with metastatic breast cancer
Mrozek, Ewa
Ramaswamy, Bhuvaneswari
Young, Donn
Rhoades, Chris A.
Kendra, Kari
Allen, Joan
Moore, Tim
Hauger, Marsha
Watson, Holly
Merriman, Nancy
Nadella, Padma
Villalona-Calero, Miguel
Shapiro, Charles L.
CLINICAL BREAST CANCER, 2006, 7 (02) : 141 - 145
[42] Weekly docetaxel and capecitabine in the treatment of advanced gastric cancer: A phase II study
Orditura, M.
Aurilio, G.
Galizia, G.
Carlomagno, C.
Lieto, E.
Vecchione, L.
Martinelli, E.
De Placido, S.
Catalano, G.
Ciardiello, F.
De Vita, F.
ANNALS OF ONCOLOGY, 2006, 17 : XI52 - XI52
[43] Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial
Barbour, A. P.
Walpole, E. T.
Mai, G. T.
Barnes, E. H.
Watson, D., I
Ackland, S. P.
Martin, J. M.
Burge, M.
Finch, R.
Karapetis, C. S.
Shannon, J.
Nott, L. M.
Varma, S.
Marx, G.
Falk, G. L.
Gebski, V
Oostendorp, M.
Wilson, K.
Thomas, J.
Lampe, G.
Zalcberg, J. R.
Simes, J.
Smithers, B. M.
ANNALS OF ONCOLOGY, 2020, 31 (02) : 236 - 245
[44] A phase II study of radiotherapy combined with docetaxel, cisplatin, and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer
Jingu, Keiichi
Umezawa, Rei
Yamamoto, Takaya
Takahashi, Noriyoshi
Suzuki, Yu
Kishida, Keita
Omata, So
Harada, Hinako
Matsushita, Haruo
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[45] Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial
Cascinu, Stefano
Galizia, Eva
Labianca, Roberto
Ferrau, Francesco
Pucci, Francesca
Silva, Rosa Rita
Luppi, Gabriele
Beretta, Giordano Domenico
Berardi, Rossana
Scartozzi, Mario
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (01) : 37 - 43
[46] Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial
Stefano Cascinu
Eva Galizia
Roberto Labianca
Francesco Ferraù
Francesca Pucci
Rosa Rita Silva
Gabriele Luppi
Giordano Domenico Beretta
Rossana Berardi
Mario Scartozzi
Cancer Chemotherapy and Pharmacology, 2011, 68 : 37 - 43
[47] A phase II study of 5-fluorouracil, leucovorin and cisplatin (FLP) for metastatic gastric cancer
Ychou, M
Astre, C
Rouanet, P
Fabre, JM
SaintAubert, B
Domergue, J
Ribard, D
Ciurana, AJ
Janbon, C
Pujol, H
EUROPEAN JOURNAL OF CANCER, 1996, 32A (11) : 1933 - 1937
[48] Weekly docetaxel and cisplatin with capecitabine and bevacizumab (AVDCX) in patients with advanced esophagogastric cancer: Results of a phase Ib/II study
Purim, Ofer
Kundel, Yulia
Gonik, Udi Sadeh
Idelevich, Efraim
Medalia, Gal
Gordon, Noa
Sulkes, Aaron
Brenner, Baruch
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[49] A phase II trial of docetaxel, cisplatin and 5-fluorouracil in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN)
Baghi, M
Hambek, M
Wagenblast, J
May, A
Wolfgang
Gstoettner
Knecht, R
ANTICANCER RESEARCH, 2006, 26 (1B) : 585 - 590
[50] Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: a multicenter phase II trial
Ferri, L. E.
Ades, S.
Alcindor, T.
Chasen, M.
Marcus, V.
Hickeson, M.
Artho, G.
Thirlwell, M. P.
ANNALS OF ONCOLOGY, 2012, 23 (06) : 1512 - 1517

← 1 2 3 4 5 →